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Eur J Vasc Endovasc Surg (2015) 50, 273e280EDITORS’ INTRODUCTIONTrans-Atlantic Debate: Is an “Endovascular First” Strategy the Optimal
Approach for Treating Acute Mesenteric Ischemia?
A.R. Naylor, Editor-in-Chief, European Journal of Vascular and Endovascular Surgery *
Vascular Research Group, Division of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Inﬁrmary, Leicester LE2 7LX, UK
T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, University of Toronto, Toronto, ON, CanadaAcute mesenteric ischemia continues to be a life-
threatening insult in often elderly patients with many
comorbidities. Recognition and correct diagnosis can be an
issue, leading to delays in therapy resulting in loss of bowel
and/or life. The basic surgical principals in treating acute
mesenteric ischemia have long been early recognition,resuscitation, urgent revascularization, resection of necrotic
bowel, and reassessment with second-look laparatomies.
Endovascular techniques now offer a less invasive alterna-
tive but it is unclear whether an endovascular ﬁrst or open
surgery ﬁrst approach is preferred in the majority of pa-
tients. Our discussants will attempt to clarify these issues.*Corresponding author.
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http://dx.doi.org/10.1016/j.ejvs.2015.04.024Part One: For the Motion. An Endovascular First Strategy is the Optimal
Approach for Treating Acute Mesenteric Ischemia
M. Björck
Institution of Surgical Sciences, Uppsala University, Uppsala, SwedenThis debate is to be as evidence based as possible. The ﬁrst
point to establish, however, is that there have been no
randomized controlled trials (RCTs) comparing an endovas-
cular ﬁrst versus an open surgery ﬁrst strategy for the
treatment of acute mesenteric ischemia (AMI), as there
have been for ruptured aortic aneurysm repair.1 Given that
AMI is relatively uncommon and usually presents as an
emergency, there probably never will be an RCT to study
this issue. However, according to the GRADE guidelines,2
data from observational studies can be valuable, provided
certain criteria are met, including that the risk of bias must
be minimized, data should be consistent, and confounding
factors need to be controlled for.
Most published reports are single-center series, with all
the methodological problems related to that type of study
design, in particular publication bias. A recent example is
from Kuopio University Hospital, Finland, which reported a
5-year consecutive series of patients with AMI, during
which time an endovascular ﬁrst strategy was applied,which was feasible in 88% of cases.3 Mortality was a
commendable 32% and in half of the cases where endo-
vascular therapy (EVT) failed, surgical bypass was ultimately
successful. These survival rates compare favorably with the
experience of the opponents of this debate (in another
single-center series), who reported 30-day mortality rates of
62% after the treatment of acute arterial thrombosis and
59% after arterial embolism, where a policy of open surgery
ﬁrst was the primary treatment strategy.4
One important group of patients with AMI are those who
develop acute upon chronic ischemia. In another publica-
tion from Endean’s group on the treatment of patients with
chronic mesenteric ischemia, high mortality rates are re-
ported in patients in whom a vein graft was used as the
bypass conduit (16% vs. 5% amongst those who had a
prosthetic graft; p ¼ .039).5 Patients in whom a vein graft
was used underwent emergency surgery more often (16%
vs. 4%; p ¼ .012) and more often had a contaminated
surgical site (30% vs. 7%; p ¼ .001). The authors concluded
